ARTICLE | Product Development
Biopharma execs highlight regulatory collaboration, call for increased manufacturing, data sharing
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
March 24, 2020 6:18 PM UTC
Updated on Mar 28, 2020 at 1:47 AM UTC
Executives at biopharmas developing vaccines and therapeutics to treat COVID-19 provided updates on clinical timelines, the positive impact of regulatory collaboration and the need to dramatically expand manufacturing capacity in order to respond more quickly to future pandemics.
The comments came during a live virtual panel at the BIO-Europe Spring conference on Monday...